Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Reduced burden of diabetes and improved quality of life: Experiences from unrestricted day-and-night hybrid closed-loop use in very young children with type 1 diabetes.

Musolino G, Dovc K, Boughton CK, Tauschmann M, Allen JM, Nagl K, Fritsch M, Yong J, Metcalfe E, Schaeffer D, Fichelle M, Schierloh U, Thiele AG, Abt D, Kojzar H, Mader JK, Slegtenhorst S, Ashcroft N, Wilinska ME, Sibayan J, Cohen N, Kollman C, Hofer SE, Fröhlich-Reiterer E, Kapellen TM, Acerini CL, de Beaufort C, Campbell F, Rami-Merhar B, Hovorka R; Kidsap Consortium.

Pediatr Diabetes. 2019 May 29. doi: 10.1111/pedi.12872. [Epub ahead of print]

PMID:
31140654
2.

Closed-loop insulin delivery in end-of-life care: a case report.

Boughton CK, Bally L, Hartnell S, Wilinska M, Coll AP, Evans M, Stettler C, Hovorka R.

Diabet Med. 2019 Apr 19. doi: 10.1111/dme.13974. [Epub ahead of print]

PMID:
31002426
3.

Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trial.

Boughton CK, Bally L, Martignoni F, Hartnell S, Herzig D, Vogt A, Wertli MM, Wilinska ME, Evans ML, Coll AP, Stettler C, Hovorka R.

Lancet Diabetes Endocrinol. 2019 May;7(5):368-377. doi: 10.1016/S2213-8587(19)30061-0. Epub 2019 Mar 29.

4.

Advances in artificial pancreas systems.

Boughton CK, Hovorka R.

Sci Transl Med. 2019 Mar 20;11(484). pii: eaaw4949. doi: 10.1126/scitranslmed.aaw4949. Review.

PMID:
30894501
5.

Preventing Hypoglycemia Following Treatment of Hyperkalemia in Hospitalized Patients.

Boughton CK, Dixon D, Goble E, Burridge A, Cox A, Noble-Bell G, Bell C, Fidler B, Chudley J, Anderson C, Cavell G, Mustafa OG.

J Hosp Med. 2019 May;14(5):284-287. doi: 10.12788/jhm.3145.

PMID:
30794138
6.

Is an artificial pancreas (closed-loop system) for Type 1 diabetes effective?

Boughton CK, Hovorka R.

Diabet Med. 2019 Mar;36(3):279-286. doi: 10.1111/dme.13816. Epub 2018 Oct 16. Review.

PMID:
30183096
7.

Neuromedin B stimulates the hypothalamic-pituitary-gonadal axis in male rats.

Boughton CK, Patel SA, Thompson EL, Patterson M, Curtis AE, Amin A, Chen K, Ghatei MA, Bloom SR, Murphy KG.

Regul Pept. 2013 Nov 10;187:6-11. doi: 10.1016/j.regpep.2013.10.002. Epub 2013 Oct 10.

PMID:
24120470
8.

Can neuropeptides treat obesity? A review of neuropeptides and their potential role in the treatment of obesity.

Boughton CK, Murphy KG.

Br J Pharmacol. 2013 Dec;170(7):1333-48. doi: 10.1111/bph.12037. Review.

9.

Cerebellin1 is a novel orexigenic peptide.

Gardiner JV, Beale KE, Roy D, Boughton CK, Bataveljic A, Campbell DC, Bewick GA, Patel NA, Patterson M, Leavy EM, Ghatei MA, Bloom SR, Dhillo WS.

Diabetes Obes Metab. 2010 Oct;12(10):883-90. doi: 10.1111/j.1463-1326.2010.01247.x.

PMID:
20920041
10.

Alarin stimulates food intake and gonadotrophin release in male rats.

Boughton CK, Patterson M, Bewick GA, Tadross JA, Gardiner JV, Beale KE, Chaudery F, Hunter G, Busbridge M, Leavy EM, Ghatei MA, Bloom SR, Murphy KG.

Br J Pharmacol. 2010 Oct;161(3):601-13. doi: 10.1111/j.1476-5381.2010.00893.x.

11.

Augurin stimulates the hypothalamo-pituitary-adrenal axis via the release of corticotrophin-releasing factor in rats.

Tadross JA, Patterson M, Suzuki K, Beale KE, Boughton CK, Smith KL, Moore S, Ghatei MA, Bloom SR.

Br J Pharmacol. 2010 Apr;159(8):1663-71. doi: 10.1111/j.1476-5381.2010.00655.x. Epub 2010 Mar 8.

Supplemental Content

Loading ...
Support Center